JOINT FILING AGREEMENTJoint Filing Agreement • August 2nd, 2013 • SC Fundamental Value Fund, L.P. • Pharmaceutical preparations
In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13G (including amendments thereto) with respect to the Common Stock of Transcept Pharmaceuticals, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, hereby execute this Agreement this 1st day of August, 2013.
